It is necessary to explore the pharmacokinetics of compounds highlighting sex-related differences, and their safety during pregnancy and lactation. Taking care of differences between women and men should represent a main focus of research, while being a primary target towards a really tailored pharmacological treatment of PTSD.
Keyphrases
- polycystic ovary syndrome
- pregnancy outcomes
- healthcare
- middle aged
- cervical cancer screening
- palliative care
- quality improvement
- breast cancer risk
- pregnant women
- insulin resistance
- metabolic syndrome
- posttraumatic stress disorder
- dairy cows
- combination therapy
- preterm infants
- skeletal muscle
- affordable care act
- drug induced